Articles
Asset Management, Data Standards, Unique Device Identifier (UDI), Leadership
AHRMM Comment Letter to FDA Regarding the Draft Guidance for Industry on the Global Unique Device Identification Database (GUDID)
On November 21, 2013, AHRMM submitted electronically
Benchmarking, Products and Services Contracting, Distribution, Financial Management, Lean/Six Sigma, Strategic Planning
Global Unique Device Identification Database (GUDID) Draft Guidance for Industry
This page provides information about submitting data to the database for device Labelers, entities responsible for providing the data to the GUDID.
Career/Professional Development
Contracts Assistant
Capital Equipment, Clinical Resource Management (CRM), Cost Management, Cost, Quality and Outcomes (CQO) Movement, Physician Preference Items (PPI), Strategic Sourcing, Value Analysis
Senior Contract Specialist
Senior Contract Specialist job description.
Capital Equipment, Distribution, Regulations and Regulatory Advocacy, Procurement
IRS Issues Final Rule Implementing Medical Device Excise Tax
An announcement of the Final Rule issued by the IRS.
Cost Management, Financial Management, Regulations and Regulatory Advocacy, Procurement
Medical Device Excise Tax - What You Should Know
The Medical Device Excise Tax, a component of the Affordable Care Act, is approaching implementation at the beginning of 2013. The tax is intended to provide an estimated $20 billion in tax revenues to help pay for the expansion of health coverage to 32 million uninsured Americans. Healthcare supply chain leaders have until May 7, 2012, to comment on the way in which the Internal Revenue Service (IRS) intends to implement this new tax.
Cost, Quality and Outcomes (CQO) Movement, Data Standards, Materials Management Information System (MMIS), Regulations and Regulatory Advocacy, Suppliers, Leadership
The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Products and Services Contracting, Purchased Services, Strategic Sourcing, Suppliers
Service Contracts: Impacting the Total Cost of Ownership
Price: Member: FREE | Non-Member: $99.00 CEC Hours: 1